ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

Efficacy of Poria cocos and Alismatis rhizoma against diet-induced hyperlipidemia in rats based on transcriptome sequencing analysis

Zhou, Xiaowen; Luo, Jingbiao; Lin, Shuxian; Wang, Yaxin; Yan, Zhenqian; Ren, Qi; Liu, Xiaoqi; Li, Xiantao*广州中医药大学
Scientific Reports2023-10-15DOI: 10.1038/s41598-023-43954-6
18阅读
引用收藏
分享

摘要

Hyperlipidemia, a common metabolic disease, is a risk factor for cardiovascular diseases, Poria cocos (PC) and Alismatis rhizoma (AR) serve as a potential treatment. A systematic approach based on transcriptome sequencing analysis and bioinformatics methods was developed to explore the synergistic effects of PC-AR and identify major compounds and potential targets. The phenotypic characteristics results indicated that the high dose (4.54 g/kg) of PC-AR reduced total cholesterol (TC), elevated high-density lipoprotein cholesterol (HDL-C) levels, and improved hepatocyte morphology, as assessed via hematoxylin and eosin (H&E) staining. Transcriptomic profiling processing results combined with GO enrichment analysis to identify the overlapping genes were associated with inflammatory responses. The cytokine-cytokine receptor interaction pathway was found as a potential key pathway using geneset enrichment analysis. Core enrichment targets were selected according to the PC-AR's fold change versus the model. Real-time quantitative PCR analysis validated that PC-AR significantly downregulated the expression of Cxcl10, Ccl2, Ccl4, Cd40 and Il-1 beta mRNA (P < 0.05). Molecular docking analysis revealed the significant compounds of PC-AR and the potential binding patterns of the critical compounds and targets. This study provides further evidence that the therapeutic effects of PC-AR on hyperlipidemia in rats through the regulation of inflammation-related targets.

学科与关键词

关键词
MICEMACROPHAGESEXPRESSION
相关
加载中…
  • Study on the Mechanism of Huanglian Jiedu Decoction in Treating Dyslipidemia Based on Network Pharmacology
    Gong, Zhaohui; Li, Rong; Chen, Shulin; Wu, Hui; Cai, Yinhe; Li, Junlong; Zhao, Xinjun; Chu, Qingmin; Luo, Chuanjin; Qing, Lijin; Li, Nan*; Wu, Wei*Journal of Healthcare Engineering, 2022, 2022: 2457706.被引 2
  • Molecular Mechanism of Crataegi Folium and Alisma Rhizoma in the Treatment of Dyslipidemia Based on Network Pharmacology and Molecular Docking
    Wang, Hui; Wang, Hua; Zhang, Jin; Luo, Jiahui; Peng, Caidong; Tong, Xiaoyun*; Chen, XudongEvidence-based Complementary and Alternative Medicine, 2022, 2022: 4891370.被引 5
  • Effects of Poria cocos extract on metabolic dysfunction-associated fatty liver disease via the FXR/PPARa-SREBPs pathway
    He, Jinbiao; Yang, Yu; Zhang, Fan; Li, Yanjuan; Li, Xiaosi; Pu, Xuemei; He, Xudong; Zhang, Mei; Yang, Xinxing; Yu, Qiuman; Qi, Yan*; Li, Xuefang*; Yu, Jie*Frontiers in Pharmacology, 2022, 13: 1007274.被引 7
查看全部 →

发表信息

论文状态
公开发表
期刊
Scientific Reports
发表日期
2023-10-15
卷期
第 13 卷, 第 1 期
页码
17493
DOI
10.1038/s41598-023-43954-6
语言
ENGLISH
成果收录
SCIE
资助标注
Natural Science Foundation of Guangdong Province [2020A1515010725]; Key Areas of Research and Development Plan of Guangdong Province [2020B1111100001]

作者

  • Z

    Zhou, Xiaowen (第一作者)

    2 · guangzhou univ chinese med

  • L

    Luo, Jingbiao

    guangzhou univ chinese med

查看全部 8 位作者收起作者
  • L

    Lin, Shuxian

    guangzhou univ chinese med

  • W

    Wang, Yaxin

    guangzhou univ chinese med

  • Y

    Yan, Zhenqian

    guangzhou univ chinese med

  • R

    Ren, Qi

  • L

    Liu, Xiaoqi

  • L

    Li, Xiantao (通讯)

    guangzhou univ chinese med

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417